Chemours Company (The) (CC) Financials
CC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 8.0 billion | 7.2 billion |
| 2023-12-31 | 8.3 billion | 7.5 billion |
| 2023-09-30 | 7.9 billion | 7.2 billion |
| 2023-06-30 | 7.7 billion | 6.9 billion |
CC Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -392.0 million | 1.0 million |
| 2023-12-31 | 349.0 million | 5.0 million |
| 2023-09-30 | 44.0 million | 6.0 million |
| 2023-06-30 | 3.0 million | 3.0 million |
CC Net Income
| Date | Net Income |
|---|---|
| 2024-03-31 | 52.0 million |
| 2023-12-31 | -26.0 million |
| 2023-09-30 | 19.0 million |
| 2023-06-30 | -376.0 million |
CC Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 746.0 million | - | 251.0 million |
| 2023-12-31 | 1.8 billion | - | 261.0 million |
| 2023-09-30 | 852.0 million | 3.9 billion | 207.0 million |
| 2023-06-30 | 738.0 million | 3.6 billion | 196.0 million |
CC Shares Outstanding
CC Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 102.0 million | 28.0 million | 142.0 million | - |
| 2023-12-31 | 135.0 million | 26.0 million | 223.0 million | - |
| 2023-09-30 | 86.0 million | 28.0 million | 165.0 million | - |
| 2023-06-30 | 58.0 million | 28.0 million | 779.0 million | - |
CC Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 1.4 billion | 1.1 billion |
| 2023-12-31 | 1.4 billion | 1.1 billion |
| 2023-09-30 | 1.5 billion | 1.2 billion |
| 2023-06-30 | 1.6 billion | 1.2 billion |
CC
Price: $28.89
Dividend Yield: 0.04%
Forward Dividend Yield: 3.46%
Payout Ratio: -62.50%
Dividend Per Share: 1.00 USD
Earnings Per Share: -2.22 USD
P/E Ratio: -13.45
Exchange: NYQ
Sector: Basic Materials
Industry: Specialty Chemicals
Volume: 829400
Ebitda: 353.0 millionMarket Capitalization: 4.2 billion
Average Dividend Frequency: 4
Years Paying Dividends: 10
DGR5: 30.00%